TriSalus this week launched its TriNac Infusion System.
The infusion system is powered by the company’s Pressure-Enabled Drug Delivery (PEDD) approach with SmartValve technology and is designed to help with the infusion barriers that can limit therapeutic uptake in solid tumors. It gives interventional radiologists intravascular tumor access and improved traceability, compatibility with standard angiographic catheters.
Get the full story on our sister site, Drug Delivery Business News.
